MARKET

SIBN

SIBN

SI-BONE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

21.55
+0.11
+0.51%
Closed 16:00 08/13 EDT
OPEN
21.25
PREV CLOSE
21.44
HIGH
21.95
LOW
21.25
VOLUME
230.58K
TURNOVER
--
52 WEEK HIGH
23.10
52 WEEK LOW
7.20
MARKET CAP
616.98M
P/E (TTM)
-12.4884
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SIBN stock price target is 25.00 with a high estimate of 28.00 and a low estimate of 22.00.

EPS

SIBN News

More
SI-BONE shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. Morgan Stanley also maintained an Overweight rating on the stock and raised its price target from $20 to $25 per share.
Benzinga · 08/04 17:06
Did Hedge Funds Make The Right Call On SI-BONE, Inc. (SIBN) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which
Insider Monkey · 08/04 14:59
Morgan Stanley Maintains Overweight on SI-BONE, Raises Price Target to $25
Morgan Stanley maintains SI-BONE (NASDAQ:SIBN) with a Overweight and raises the price target from $20 to $25.
Benzinga · 08/04 12:42
SI-BONE EPS beats by $0.22, beats on revenue
SI-BONE (NASDAQ:SIBN): Q2 GAAP EPS of -$0.44 beats by $0.22. Revenue of $14.05M (-13.9% Y/Y) beats by $5.27M. Press Release
seekingalpha · 08/04 01:16
Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates
Si-Bone (SIBN) delivered earnings and revenue surprises of 31.25% and 48.20%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/03 23:05
SI-BONE Q2 EPS $(0.44) Beats $(0.64) Estimate, Sales $14.00M Beat $8.29M Estimate
SI-BONE (NASDAQ:SIBN) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.64) by 31.25 percent. This is a 25.71 percent decrease over losses of $(0.35) per share from the same
Benzinga · 08/03 20:27
SI-BONE, Inc. Reports Second Quarter 2020 Financial Results
SANTA CLARA, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended June 30, 2020. Recen
GlobeNewswire · 08/03 20:05
SI-BONE to Present at the 40th Annual Canaccord Genuity Growth Conference
SANTA CLARA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced today that the company will be participating in the upcomin
GlobeNewswire · 07/30 20:09

Industry

Medical Equipment, Supplies & Distribution
+0.61%
Healthcare Equipment & Supplies
+0.64%

Hot Stocks

Symbol
Price
%Change

About SIBN

SI-BONE, Inc. is focused on development of medical devices. The Company is engaged in the development, manufacture and commercialization of minimally invasive surgical devices for the treatment of patients with low back symptoms related to certain sacroiliac (SI) joint disorders. The Company offers iFuse Implant System, which provides a minimally invasive surgical solution to fuse the SI joint using patented triangular titanium implants that create an interference fit within the ilium and sacrum. The triangular implant shape, combined with the press fit insertion, is designed to provide fixation by minimizing rotational motion. The implants has a porous surface that provide an environment for bone ongrowth and ingrowth, facilitating long-term fusion of the joint. The iFuse Implant System is intended for sacroiliac fusion for conditions, including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis.
More

Webull offers kinds of SI-Bone Inc stock information, including NASDAQ:SIBN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIBN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SIBN stock methods without spending real money on the virtual paper trading platform.